Detalhe da pesquisa
1.
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders.
Br J Haematol
; 201(4): 628-639, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806152
2.
Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy.
J Antimicrob Chemother
; 75(11): 3327-3333, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32728708
3.
Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data.
J Sex Med
; 17(1): 142-151, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31735612
4.
Prevalence of transmitted drug resistance mutations among newly diagnosed HIV-1-infected patients in a large teaching hospital of the Northern Italy.
J Med Virol
; 92(8): 929-931, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297982
5.
Neutralizing monoclonal antibodies for early treatment of hospital-acquired SARS-CoV-2 infection in hematologic patients.
EJHaem
; 2022 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36248618
6.
Short Communication: No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir.
AIDS Res Hum Retroviruses
; 37(3): 204-206, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33126811
7.
Sweet syndrome and secondary syphilis: a rare association that should not be missed.
Ital J Dermatol Venerol
; 159(3): 367-368, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38619201